Can we modify transplant outcome by improving lymphocyte recovery?

References

• Schmidmaier R, Then C, Schnabel B, Oduncu F, Baumann P, Straka C. CD4+ CD28+ lymphocytes on day 5 after high-dose melphalan for multiple myeloma predict a low risk of infections during severe neutropenia and are associated with the number of reinfused T lymphocytes of the autologous stem cell graft. Cytotherapy. 2011 May 23. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Barrett AJ, Savani BN. Does chemotherapy modify the immune surveillance of hematological malignancies? Leukemia. 2009;23:53–8.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Barrett AJ, Schaffer M, Hägglund H, Ljungman P, Ringdén O, . Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies. Biol Blood Marrow Transplant. 2009;15:1108–15.
   PubMed Web of Science ®Google Scholar
• Savani BN, Mielke S, Rezvani K, Montero A, Yong AS, Wish L, . Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2007;13:1216–23.
   PubMed Web of Science ®Google Scholar
• Tedeschi SK, Jagasia M, Engelhardt BG, Domm J, Kassim AA, Chinratanalab W, . Early lymphocyte reconstitution is associated with improved transplant outcome after cord blood transplantation. Cytotherapy. 2011;13:78–82.
   PubMed Web of Science ®Google Scholar
• Porrata LF, Markovic SN. Autograft mediated adoptive immunotherapy of cancer in the context of autologous stem cell transplantation. World J Clin Oncol. 2010;1:29–34.
   PubMedGoogle Scholar
• Burke MJ, Vogel RI, Janardan SK, Brunstein C, Smith AR, Miller JS, . Early lymphocyte recovery and outcomes after umbilical cord blood transplantation (UCBT) for hematologic malignancies. Biol Blood Marrow Transplant. 2011;17:831–40.
   PubMed Web of Science ®Google Scholar
• Ege H, Gertz MA, Markovic SN, Lacy MQ, Dispenzieri A, Hayman SR, . Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study. Br J Haematol. 2008;141:792–8.
   PubMed Web of Science ®Google Scholar
• Matthews K, Lim Z, Pearce L, Pagliuca A, Alejandro Madrigal J, Mufti GJ, . Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab. Br J Haematol. 2010;149:879–89.
   PubMed Web of Science ®Google Scholar
• Stover DG, Reddy VK, Shyr Y, Savani BN, Reddy N. Long-term impact of prior rituximab therapy and early lymphocyte recovery on auto-SCT outcome for diffuse large B-cell lymphoma. Bone Marrow Transplant. 2011 Feb 28. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Saliba RM, Komanduri KV, Giralt S, de Souza J, Patah P, Oran B, . Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML. Bone Marrow Transplant. 2009;43:685–92.
   PubMed Web of Science ®Google Scholar
• Meehan KR, Talebian L, Wu J, Hill JM, Szczepiorkowski ZM, Sentman CL, Ernstoff MS. Immune mobilization of autologous blood progenitor cells: direct influence on the cellular subsets collected. Cytotherapy. 2010;12:1013–21.
   PubMed Web of Science ®Google Scholar
• Uchida N, Bonifacino A, Krouse AE, Metzger ME, Csako G, Lee-Stroka A, . Accelerated lymphocyte reconstitution and long-term recovery after transplantation of lentiviral-transduced rhesus CD34(+) cells mobilized by G-CSF and plerixafor. Exp Hematol. 2011 Apr 15. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Condomines M, Quittet P, Lu ZY, Nadal L, Latry P, Lopez E, . Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor. J Immunol. 2006;176:6631–9.
   PubMed Web of Science ®Google Scholar
• Eksioglu EA, Kielbasa J, Eisen S, Reddy V. Granulocyte–macrophage colony-stimulating factor increases the proportion of circulating dendritic cells after autologous but not after allogeneic hematopoietic stem cell transplantation. Cytotherapy. 2011 May 24. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Narayanasami U, Kanteti R, Morelli J, Klekar A, Al-Olama A, Keating C, . Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation. Blood. 2001;98:2059–64.
   PubMed Web of Science ®Google Scholar
• Satwani P, van de Ven C, Ayello J, Cairo D, Simpson LL, Baxi L, Cairo MS. Interleukin (IL)-15 in combination with IL-2, fms-like tyrosine kinase-3 ligand and anti-CD3 significantly enhances umbilical cord blood natural killer (NK) cell and NK-cell subset expansion and NK function. Cytotherapy. 2011;13:730–8.
   PubMed Web of Science ®Google Scholar
• Alpdogan O, van den Brink MR. IL-7 and IL-15: therapeutic cytokines for immunodeficiency. Trends Immunol. 2005; 26:56–64.
   PubMed Web of Science ®Google Scholar
• Kang Y, Chen BJ, Deoliveira D, Mito J, Chao NJ. Selective enhancement of donor hematopoietic cell engraftment by the CXCR4 antagonist AMD3100 in a mouse transplantation model. PLoS One. 2010;5:e11316.
   PubMed Web of Science ®Google Scholar